Metropolitan Life Insurance Company (MetLife)’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,899
| Closed | -$8.23K | – | 121 |
|
|
2024
Q1 | $8.23K | Hold |
2,899
| – | – | ﹤0.01% | 2194 |
|
|
2023
Q4 | $42.7K | Hold |
2,899
| – | – | ﹤0.01% | 1533 |
|
|
2023
Q3 | $53.1K | Hold |
2,899
| – | – | ﹤0.01% | 1368 |
|
|
2023
Q2 | $62.5K | Hold |
2,899
| – | – | ﹤0.01% | 1296 |
|
|
2023
Q1 | $85.1K | Sell |
2,899
-251
| -8% | -$7.36K | ﹤0.01% | 1089 |
|
|
2022
Q4 | $116K | Buy |
3,150
+943
| +43% | +$34.8K | 0.01% | 972 |
|
|
2022
Q3 | $62.1K | Buy |
2,207
+1,412
| +178% | +$39.7K | ﹤0.01% | 1309 |
|
|
2022
Q2 | $15.3K | Hold |
795
| – | – | ﹤0.01% | 2166 |
|
|
2022
Q1 | $10.2K | Buy |
+795
| New | +$10.2K | ﹤0.01% | 2233 |
|